[HTML][HTML] Lipid-based nanocarriers in renal RNA therapy
CT Su, DHW See, JW Huang - Biomedicines, 2022 - mdpi.com
Kidney disease is a multifactorial problem, with a growing prevalence and an increasing
global burden. With the latest worldwide data suggesting that chronic kidney disease (CKD) …
global burden. With the latest worldwide data suggesting that chronic kidney disease (CKD) …
[PDF][PDF] Lipid-Based Nanocarriers in Renal RNA Therapy. Biomedicines 2022, 10, 283
CT Su, DHW See, JW Huang - 2022 - pdfs.semanticscholar.org
Kidney disease is a multifactorial problem, with a growing prevalence and an increasing
global burden. With the latest worldwide data suggesting that chronic kidney disease (CKD) …
global burden. With the latest worldwide data suggesting that chronic kidney disease (CKD) …
[HTML][HTML] Lipid-Based Nanocarriers in Renal RNA Therapy
CT Su, DHW See, JW Huang - Biomedicines, 2022 - ncbi.nlm.nih.gov
Kidney disease is a multifactorial problem, with a growing prevalence and an increasing
global burden. With the latest worldwide data suggesting that chronic kidney disease (CKD) …
global burden. With the latest worldwide data suggesting that chronic kidney disease (CKD) …
Lipid-Based Nanocarriers in Renal RNA Therapy
CT Su, DHW See, JW Huang - Biomedicines, 2022 - pubmed.ncbi.nlm.nih.gov
Kidney disease is a multifactorial problem, with a growing prevalence and an increasing
global burden. With the latest worldwide data suggesting that chronic kidney disease (CKD) …
global burden. With the latest worldwide data suggesting that chronic kidney disease (CKD) …
Lipid-Based Nanocarriers in Renal RNA Therapy.
CT Su, DHW See, JW Huang - Biomedicines, 2022 - search.ebscohost.com
Kidney disease is a multifactorial problem, with a growing prevalence and an increasing
global burden. With the latest worldwide data suggesting that chronic kidney disease (CKD) …
global burden. With the latest worldwide data suggesting that chronic kidney disease (CKD) …
Lipid-Based Nanocarriers in Renal RNA Therapy
S Chi-Ting, DHW See, JW Huang - Biomedicines, 2022 - search.proquest.com
Kidney disease is a multifactorial problem, with a growing prevalence and an increasing
global burden. With the latest worldwide data suggesting that chronic kidney disease (CKD) …
global burden. With the latest worldwide data suggesting that chronic kidney disease (CKD) …
Lipid-Based Nanocarriers in Renal RNA Therapy.
CT Su, DHW See, JW Huang - Biomedicines, 2022 - europepmc.org
Kidney disease is a multifactorial problem, with a growing prevalence and an increasing
global burden. With the latest worldwide data suggesting that chronic kidney disease (CKD) …
global burden. With the latest worldwide data suggesting that chronic kidney disease (CKD) …
Lipid-Based Nanocarriers in Renal RNA Therapy
CT Su, DHW See, JW Huang - 2022 - agris.fao.org
Kidney disease is a multifactorial problem, with a growing prevalence and an increasing
global burden. With the latest worldwide data suggesting that chronic kidney disease (CKD) …
global burden. With the latest worldwide data suggesting that chronic kidney disease (CKD) …
Lipid-Based Nanocarriers in Renal RNA Therapy.
CT Su, DHW See, JW Huang - Biomedicines, 2022 - europepmc.org
Kidney disease is a multifactorial problem, with a growing prevalence and an increasing
global burden. With the latest worldwide data suggesting that chronic kidney disease (CKD) …
global burden. With the latest worldwide data suggesting that chronic kidney disease (CKD) …